Golubev AG - Search Results

1

Melatonin Administered before or after a Cytotoxic Drug Increases Mammary Cancer Stabilization Rates in HER2/Neu Mice.

Panchenko AV, Tyndyk ML, Maydin MA, Baldueva IA, Artemyeva AS, Kruglov SS, Kireeva GS, Golubev AG, Belyaev AM, Anisimov VN. Panchenko AV, et al. Among authors: golubev ag. Chemotherapy. 2020;65(1-2):42-50. doi: 10.1159/000509238. Epub 2020 Aug 7. Chemotherapy. 2020. PMID: 32772021

2

In mice transgenic for IGF1 under keratin-14 promoter, lifespan is decreased and the rates of aging and thymus involution are accelerated.

Anisimov VN, Labunets IF, Popovich IG, Tyndyk ML, Yurova MN, Golubev AG. Anisimov VN, et al. Among authors: golubev ag. Aging (Albany NY). 2019 Apr 13;11(7):2098-2110. doi: 10.18632/aging.101903. Aging (Albany NY). 2019. PMID: 30981207 Free PMC article.

3

Aging and cancer: Is glucose a mediator between them?

Golubev AG, Anisimov VN. Golubev AG, et al. Oncotarget. 2019 Nov 26;10(63):6758-6767. doi: 10.18632/oncotarget.27344. eCollection 2019 Nov 26. Oncotarget. 2019. PMID: 31827719 Free PMC article.

4

[Gender-specific effects of neonatal administration of melatonin on lifespan and age-associated patholgy in 129/Sv mice.].

Yurova MN, Tyndyk ML, Popovich IG, Golubev AG, Anisimov VN. Yurova MN, et al. Among authors: golubev ag. Adv Gerontol. 2019;32(1-2):66-75. Adv Gerontol. 2019. PMID: 31228370 Russian.

5

[Comparative analysis of experimental data about the effects of various polyphenols on lifespan and aging.].

Panchenko AV, Tyndyk ML, Fedoros EI, Maydin MA, Semenov AL, Gubareva EA, Golubev AG, Anisimov VN. Panchenko AV, et al. Among authors: golubev ag. Adv Gerontol. 2019;32(3):325-330. Adv Gerontol. 2019. PMID: 31512417 Russian.

6

The second European Congress on Biogerontology: from molecules to humans.

Anisimov VN, Golubev AG. Anisimov VN, et al. Among authors: golubev ag. Exp Gerontol. 2001 Jul;36(7):989-94. doi: 10.1016/s0531-5565(00)00264-3. Exp Gerontol. 2001. PMID: 11404046 No abstract available.

7

Applying parametric models to survival data: tradeoffs between statistical significance, biological plausibility, and common sense.

Golubev A, Panchenko A, Anisimov V. Golubev A, et al. Biogerontology. 2018 Oct;19(5):341-365. doi: 10.1007/s10522-018-9759-3. Epub 2018 Jun 4. Biogerontology. 2018. PMID: 29869230

8

[The lifespans of scholars referred to different disciplines according to data from diverse sources: Inferences and challenges.].

Golubev AG, Zharinov GM, Mikhalsky AI, Anisimov VN. Golubev AG, et al. Adv Gerontol. 2022;35(2):170-179. Adv Gerontol. 2022. PMID: 35727924 Review. Russian.

9

[2d European congress on biogerontology].

Anisimov VN, Golubev AG, Khavinson VKh. Anisimov VN, et al. Among authors: golubev ag. Ross Fiziol Zh Im I M Sechenova. 2001 Mar;87(3):423-7. Ross Fiziol Zh Im I M Sechenova. 2001. PMID: 11386167 Russian. No abstract available.

10

[Is aging a disease? Biogerontologist' point of view: the old age ≠ disease.].

Golubev AG. Golubev AG. Adv Gerontol. 2017;30(6):845-847. Adv Gerontol. 2017. PMID: 29608827 Russian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters